SCHEMBL67709

SCHEMBL67709

O=C1NCCC2C=CC=CC12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10157505 0.78
SCHEMBL1159917 0.75
SCHEMBL9472574 0.75 GAA (0.30)
SCHEMBL3952884 0.75 KDM4E (0.31)
SCHEMBL4342918 0.71
SCHEMBL948922 0.71
SCHEMBL20824808 0.68 RAB9A (0.30)
SCHEMBL13379597 0.67
SCHEMBL4620453 0.67 MAP3K14 (0.40)
SCHEMBL2224163 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 370 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4737443-A1 SALT-INDUCIBLE KINASE INHIBITORY COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME Tanabe Pharma Corporation (JP) 2026-05-06 EP claimed
US-20260062387-A1 SALT-INDUCIBLE KINASE INHIBITOR COMPOUND AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME MITSUBISHI TANABE PHARMA CORPORATION (JP) 2026-03-05 US claimed
WO-2024242169-A1 SALT-INDUCIBLE KINASE INHIBITORY COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME 田辺三菱製薬株式会社 2024-11-28 WO claimed
CN-117820312-A Synthesis method of tetrahydroisoquinolone tetracyclic compound 常州大学 2024-04-05 CN claimed
US-11878020-B2 Modulators of Rho-associated protein kinase REDX PHARMA PLC (GB) 2024-01-23 US claimed
US-20230021916-A1 MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE REDX PHARMA LIMITED (GB) 2023-01-26 US claimed
US-11497751-B2 Modulators of Rho-associated protein kinase REDX PHARMA PLC (GB) 2022-11-15 US claimed
EP-4026834-A1 HETEROCYCLYLAMINO-SUBSTITUTED TRIAZOLES AS MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE Redx Pharma Plc (GB) 2022-07-13 EP claimed
EP-3743420-B1 HETEROCYCLYLAMINO-SUBSTITUTED TRIAZOLES AS MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE REDX PHARMA PLC (GB) 2021-12-15 EP claimed
US-20210038606-A1 Modulators of Rho-associated Protein Kinase REDX PHARMA LIMITED (GB) 2021-02-11 US claimed
WO-1994013272-A1 USE OF POTASSIUM CHANNEL ACTIVATORS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PAIN SMITHKLINE BEECHAM PLC. (GB) 1994-06-23 WO claimed
EP-0575749-A2 Use of potassium-channel activators for the manufacture of a medicament for the treatment of gastrointertinal ulcers E.R. SQUIBB &amp; SONS, INC. (US) 1993-12-29 EP claimed
US-5262419-A Antiulcer agents E. R. SQUIBB & SONS, INC. (US) 1993-11-16 US claimed
EP-0528553-A1 Tetrahydroisoquinoline derivatives, processes for producing the same and fungicides containing the same TOSOH CORPORATION (JP) 1993-02-24 EP claimed
EP-0250077-B1 PHARMACOLOGICALLY ACTIVE BENZOPYRANES BEECHAM GROUP PLC (GB) 1992-01-02 EP claimed
EP-0205292-B1 Pyrano[3,2-c]pyridine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1991-11-06 EP claimed
EP-0372998-A2 Use of benzopyran derivatives in the treatment of epilepsy BEECHAM GROUP PLC (GB) 1990-06-13 EP claimed
EP-0250077-A2 Pharmacologically active benzopyranes BEECHAM GROUP PLC (GB) 1987-12-23 EP claimed
WO-1987007607-A1 PYRANO (3,2-c) PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BEECHAM GROUP P.L.C. (GB) 1987-12-17 WO claimed
EP-0205292-A2 Pyrano[3,2-c]pyridine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1986-12-17 EP claimed